UK markets close in 3 hours 52 minutes
  • FTSE 100

    6,876.35
    -12.77 (-0.19%)
     
  • FTSE 250

    22,165.15
    +11.60 (+0.05%)
     
  • AIM

    1,239.11
    +4.42 (+0.36%)
     
  • GBP/EUR

    1.1543
    +0.0012 (+0.11%)
     
  • GBP/USD

    1.3726
    -0.0016 (-0.12%)
     
  • BTC-GBP

    45,821.55
    +2,024.73 (+4.62%)
     
  • CMC Crypto 200

    1,334.42
    +39.83 (+3.08%)
     
  • S&P 500

    4,127.99
    -0.81 (-0.02%)
     
  • DOW

    33,745.40
    -55.20 (-0.16%)
     
  • CRUDE OIL

    60.00
    +0.30 (+0.50%)
     
  • GOLD FUTURES

    1,727.80
    -4.90 (-0.28%)
     
  • NIKKEI 225

    29,751.61
    +212.88 (+0.72%)
     
  • HANG SENG

    28,497.25
    +43.97 (+0.15%)
     
  • DAX

    15,235.61
    +20.61 (+0.14%)
     
  • CAC 40

    6,177.41
    +15.73 (+0.26%)
     

Global Intravenous (IV) Iron Drugs Market to Reach $2.6 Billion by 2027

ReportLinker
·7-min read

Abstract: - Global Intravenous (IV) Iron Drugs Market to Reach $2. 6 Billion by 2027. - Amid the COVID-19 crisis, the global market for Intravenous (IV) Iron Drugs estimated at US$1.

New York, April 07, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Intravenous (IV) Iron Drugs Industry" - https://www.reportlinker.com/p06051284/?utm_source=GNW
7 Billion in the year 2020, is projected to reach a revised size of US$2.6 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027. Ferric Carboxyl Maltose, one of the segments analyzed in the report, is projected to record a 7.4% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Iron Sucrose segment is readjusted to a revised 5.4% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $458.8 Million, While China is Forecast to Grow at 9.4% CAGR
- The Intravenous (IV) Iron Drugs market in the U.S. is estimated at US$458.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$554.7 Million by the year 2027 trailing a CAGR of 9.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.
- Other Product Types Segment to Record 4.4% CAGR
- In the global Other Product Types segment, USA, Canada, Japan, China and Europe will drive the 4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$338.9 Million in the year 2020 will reach a projected size of US$445.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$344.5 Million by the year 2027, while Latin America will expand at a 5.4% CAGR through the analysis period.

- Select Competitors (Total 21 Featured) -

  • Allergan Plc.

  • AMAG Pharmaceuticals Inc.

  • American Regent Inc.

  • Luitpold Pharmaceuticals

  • Pharmacosmos A/S

  • Sanofi US

  • Vifor Fresenius Medical Care Renal Pharma

  • Vifor Pharma Ltd.




Read the full report: https://www.reportlinker.com/p06051284/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Robo Advisory by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027 and
% CAGR

Table 2: World Historic Review for Robo Advisory by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017 and % CAGR

Table 3: World 15-Year Perspective for Robo Advisory by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2018 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 4: USA Current & Future Analysis for Robo Advisory by
Segment - Robo Advisory - Independent Analysis of Annual Sales
in US$ Million for the Years 2018 through 2027 and % CAGR

Table 5: USA Historic Review for Robo Advisory by Segment -
Robo Advisory Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017 and % CAGR

CANADA
Table 6: Canada Current & Future Analysis for Robo Advisory by
Segment - Robo Advisory - Independent Analysis of Annual Sales
in US$ Million for the Years 2018 through 2027 and % CAGR

Table 7: Canada Historic Review for Robo Advisory by Segment -
Robo Advisory Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017 and % CAGR

JAPAN
Table 8: Japan Current & Future Analysis for Robo Advisory by
Segment - Robo Advisory - Independent Analysis of Annual Sales
in US$ Million for the Years 2018 through 2027 and % CAGR

Table 9: Japan Historic Review for Robo Advisory by Segment -
Robo Advisory Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017 and % CAGR

CHINA
Table 10: China Current & Future Analysis for Robo Advisory by
Segment - Robo Advisory - Independent Analysis of Annual Sales
in US$ Million for the Years 2018 through 2027 and % CAGR

Table 11: China Historic Review for Robo Advisory by Segment -
Robo Advisory Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017 and % CAGR

EUROPE
Table 12: Europe Current & Future Analysis for Robo Advisory by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2018 through 2027 and % CAGR

Table 13: Europe Historic Review for Robo Advisory by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017 and % CAGR

Table 14: Europe 15-Year Perspective for Robo Advisory by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2018 & 2027

FRANCE
Table 15: France Current & Future Analysis for Robo Advisory by
Segment - Robo Advisory - Independent Analysis of Annual Sales
in US$ Million for the Years 2018 through 2027 and % CAGR

Table 16: France Historic Review for Robo Advisory by Segment -
Robo Advisory Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017 and % CAGR

GERMANY
Table 17: Germany Current & Future Analysis for Robo Advisory
by Segment - Robo Advisory - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027 and % CAGR

Table 18: Germany Historic Review for Robo Advisory by Segment -
Robo Advisory Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2017 and % CAGR

ITALY
Table 19: Italy Current & Future Analysis for Robo Advisory by
Segment - Robo Advisory - Independent Analysis of Annual Sales
in US$ Million for the Years 2018 through 2027 and % CAGR

Table 20: Italy Historic Review for Robo Advisory by Segment -
Robo Advisory Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017 and % CAGR

UNITED KINGDOM
Table 21: UK Current & Future Analysis for Robo Advisory by
Segment - Robo Advisory - Independent Analysis of Annual Sales
in US$ Million for the Years 2018 through 2027 and % CAGR

Table 22: UK Historic Review for Robo Advisory by Segment -
Robo Advisory Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017 and % CAGR

REST OF EUROPE
Table 23: Rest of Europe Current & Future Analysis for Robo
Advisory by Segment - Robo Advisory - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027 and
% CAGR

Table 24: Rest of Europe Historic Review for Robo Advisory by
Segment - Robo Advisory Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2017 and %
CAGR

ASIA-PACIFIC
Table 25: Asia-Pacific Current & Future Analysis for Robo
Advisory by Segment - Robo Advisory - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027 and
% CAGR

Table 26: Asia-Pacific Historic Review for Robo Advisory by
Segment - Robo Advisory Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2017 and %
CAGR

REST OF WORLD
Table 27: Rest of World Current & Future Analysis for Robo
Advisory by Segment - Robo Advisory - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027 and
% CAGR

Table 28: Rest of World Historic Review for Robo Advisory by
Segment - Robo Advisory Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2017 and %
CAGR

IV. COMPETITION
Total Companies Profiled: 44
Read the full report: https://www.reportlinker.com/p06051284/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001